✦ LIBER ✦

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Scribed by Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torres, M.; Bain, V.; Patel, K.; Cronin, P.W.; Pulkstenis, E.; Subramanian, G.M.; McHutchison, J.G.

Book ID: 122713207
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(09)61044-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1041 EFFICACY AND SAFETY OF ALBINTERFERO

1041 EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT- NAIVE, CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS

✍ Zeuzem, S.; Sulkowski, M.; Lawitz, E.; Rustgi, V.; Lurie, Y.; Grigorescu, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

818 VIRAL KINETICS AND PHARMACODYNAMICS

818 VIRAL KINETICS AND PHARMACODYNAMICS OF ALBINTERFERON ALFA-2B IN INTERFERON TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ A.U. Neumann; L. Rozenberg; V.G. Bain; J.G. McHutchison; E. Pulkstenis; G.M. Sub 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

W1016 Efficacy and Safety of Erythropoie

W1016 Efficacy and Safety of Erythropoietin-Alfa On NaïVe Patients with Chronic Hepatitis C and Genotype 1 Receiving Combination Therapy with Pegylated Interferon-Alfa 2b and Ribavirin

✍ Purcell, Dagmary; Toro, Doris H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Albinterferon alfa-2b dosed every two or

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

✍ Stefan Zeuzem; Eric M. Yoshida; Yves Benhamou; Stephen Pianko; Vincent G. Bain; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The efficacy and safety of albinterferon alfa-2b (alb-IFN), a novel recombinant protein consisting of interferon alfa-2b genetically fused to human albumin, was evaluated in a phase 2b, open-label study of patients with genotype 1, chronic hepatitis C. In all, 458 IFN-alfa treatment-naı ¨ve patients

S1939 Viral Kinetics and Pharmacodynamic

S1939 Viral Kinetics and Pharmacodynamics of Albinterferon Alfa-2b in Interferon Treatment-NaïVe Patients with Genotype 1, Chronic Hepatitis C

✍ Neumann, Avidan U.; Rozenberg, Lynn; Bain, Vincent G.; McHutchison, John G.; Pul 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

P1175 CEPEGINTERFERON-ALFA-2b IN COMBINA

P1175 CEPEGINTERFERON-ALFA-2b IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C

✍ Znoyko, O.; Klimova, E.; Maximov, S.; Kizhlo, S.; Petrochenkova, N.; Nagimova, F 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB